Aducanumab Approved for Treatment of Alzheimer's Disease
FDA approval of aducanumab for treatment of Alzheimer's
Aducanumab has been approved as a treatment for Alzheimer's by the U.S. Food and Drug Administration (FDA). Aducanumab is the first FDA- approved therapy to potentially delay decline from the disease, compared to current medications that only address symtoms.
It is also the first the...
Read More →